[1] |
Xie CB, Shaikh LH, Garg S, et al. Regulation of aldosterone secretion by Cav1.3[J]. Sci Rep, 2016, 6: 24697. doi: 10.1038/srep24697.
|
[2] |
Wang F, Ma X, Tong A, et al. The effects of different calcium channel blockers on aldosterone-producing adenoma cells[J]. Front Endocrinol(Lausanne), 2020, 11: 260. doi: 10.3389/fendo.2020.00260.
|
[3] |
Eisenhofer G, Duran C, Cannistraci CV, et al. Use of steroid profiling combined with machine learning for identification and subtype classification in primary aldosteron-ism[J]. JAMA Netw Open, 2020, 3: e2016209. doi: 10.1001/jamanetworkopen.2020.16209.
|
[4] |
Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab, 2008, 93: 3266-3281.
|
[5] |
王芬,童安莉,李玉秀.醛固酮瘤细胞原代培养方法的建立及细胞鉴定[J].基础医学与临床,2018,38:831-834.
|
[6] |
Wang Z, Wang H, Peng Y, et al. A liquid chromatography-tandem mass spectrometry(LC-MS/MS)-based assay to profile 20 plasma steroids in endocrine disorders[J]. Clin Chem Lab Med, 2020, 58: 1477-1487.
|
[7] |
Hattangady NG, Karashima S, Yuan L, et al. Mutated KCNJ5 activates the acute and chronic regulatory steps in aldosterone production[J]. J Mol Endocrinol, 2016, 57: 1-11.
|
[8] |
Tong A, Liu G, Wang F, et al. A novel phenotype of familial hyperaldosteronism type Ⅲ: concurrence of aldosteronism and cushing's syndrome[J]. J Clin Endocrinol Metab, 2016, 101: 4290-4297.
|
[9] |
Tezuka Y, Yamazaki Y, Kitada M, et al. 18-Oxocortisol synthesis in aldosterone-producing adrenocortical adenoma and significance of KCNJ5 mutation status[J]. Hypertension, 2019, 73: 1283-1290.
|
[10] |
Marques P, Courand PY, Gouin-Thibault I, et al. P-glycoprotein influences urinary excretion of aldosterone in healthy individuals[J]. J Hypertens, 2019, 37: 2225-2231.
|
[11] |
Nakamura T, Olamura N, Yagi M, et al. Effects of ABCB1 3435C>T genotype on serum levels of cortisol and aldosterone in women with normal menstrual cycles[J]. Genet Mol Res, 2009, 8: 397-403.
|
[12] |
Eap CB, Bochud M, Elston RC, et al. CYP3A5 and ABCB1 genes influence blood pressure and response to treatment, and their effect is modified by salt[J]. Hypertension, 2007, 49: 1007-1014.
|